4//SEC Filing
Kastelein Johannes Jacob Pieter 4
Accession 0000950170-25-002356
CIK 0001936258other
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:48 PM ET
Size
5.5 KB
Accession
0000950170-25-002356
Insider Transaction Report
Form 4
Kastelein Johannes Jacob Pieter
DirectorChief Scientific Officer
Transactions
- Award
Option (right to buy)
2025-01-02+200,000→ 200,000 totalExercise: $25.96Exp: 2035-01-02→ Ordinary Shares (200,000 underlying)
Footnotes (1)
- [F1]25% of the shares underlying the option will vest on January 2, 2026, the one-year anniversary of vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.
Documents
Issuer
NewAmsterdam Pharma Co N.V.
CIK 0001936258
Entity typeother
Related Parties
1- filerCIK 0002000389
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:48 PM ET
- Size
- 5.5 KB